Viewing Study NCT00682292


Ignite Creation Date: 2025-12-24 @ 3:49 PM
Ignite Modification Date: 2026-01-04 @ 10:50 AM
Study NCT ID: NCT00682292
Status: COMPLETED
Last Update Posted: 2008-05-22
First Post: 2008-05-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Daclizumab Versus Thymoglobulin in Renal Transplant Recipients With High Immunological Risk
Sponsor: University Hospital, Lille
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module